Therapy
"Ocular Myasthenic Syndrome after Interferon Therapy for Chronic Hepatitis."
Published in Hepatitis Weekly, July 29th, 1996
According to the authors' abstract of an article published in Neuro - Ophthalmology, "A 68-year-old woman suffering from chronic hepatitis complained of vertical diplopia after long-term administration of alpha-II-interferon (IFN). Ocular symptoms worsened and left ptosis appeared during IFN treatment, but disappeared after IFN therapy was discontinued. Thorough serological and neuro-ophthalmological diagnostic examinations failed to disclose any reasons for these ocular symptoms. Fatigable lid ptosis, negative results of diagnostic examinations for ocular myasthenia, and the clinical course suggest that this patient developed an ocular myasthenic syndrome secondary to IFN." The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-07-29)
More Articles from Hepatitis Weekly
- Geriatrics
Fourth HBV Injection May Benefit Older People - Blood Banking
Coagulation Factor IX Product Licensed with Added Safety Measure - Cardiology
HCV May Contribute to Heart Disease - DNA Vaccines (Hepatitis B)
DNA Vaccine for HBV Tested and Compared in Chimpanzee Model - International (Europe)
Eastern European AIDS Specialists Present Updates on Epidemics - Pathogenesis (HCV)
Researchers Characterize Factors Linked to HCV Fibrosis - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
